Obesity Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Obesity Epidemiology Forecast Report Coverage

Expert Market Research's “Obesity Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of Obesity. It projects the future incidence and prevalence rates of Obesity cases across various populations. The study covers age, gender, and type as major determinants of the Obesity population. The report highlights patterns in the prevalence of Obesity over time and projects future trends based on multiple variables.

Obesity Understanding: Disease Overview

Obesity is a chronic condition characterized by excess body fat, leading to elevated health risks, including cardiovascular disease, diabetes, hypertension, and certain cancers. It results from an imbalance between caloric intake and expenditure, influenced by genetics, lifestyle, and environmental factors. Classification includes overweight, Class I–III obesity, and syndromic or secondary obesity. Fat distribution patterns, such as abdominal (android) or hip/thigh (gynoid), further affect metabolic risk. Obesity significantly impacts quality of life, mobility, and psychosocial health, making early intervention and structured management critical for long-term outcomes.

Obesity Epidemiology Perspective

The Obesity epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the Obesity epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Obesity and their trends. The Obesity detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• In 2022, approximately 2.5 billion adults (18+ years) were classified as overweight globally, including 890 million with obesity, representing 43% overweight and 16% obese among adults.
• Since 1990, adult obesity prevalence has more than doubled, and adolescent obesity has quadrupled, reflecting a rapid global increase in overweight conditions.
• By 2024, an estimated 35 million children under 5 were overweight, while over 390 million children and adolescents aged 5-19 were overweight in 2022.
• Among youths aged 5-19, overweight prevalence increased from 8% in 1990 to 20% in 2022, affecting both boys and girls similarly.

Read more about this report - Request a Free Sample

Country-wise Obesity Epidemiology Segment

The Obesity epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

In the United Kingdom, government statistics indicate that obesity prevalence remains high, with around 64% of adults living with overweight or obesity and 28% classified as obese, highlighting significant health inequalities. Also, in the United States, obesity and overweight remain significant public health challenges. Recent CDC data show that 40.3 % of adults aged 20 and older were classified as obese from 2021-2023, while 73.6 % of adults were overweight or obese overall. Among youth, obesity prevalence was 22.9 % for ages 12-19, 22.1 % for ages 6-11, and 14.9 % for ages 2-5, reflecting persistent excess weight across age groups. These patterns underscore the ongoing need for prevention, early intervention, and comprehensive weight management strategies in U.S. populations.

Obesity: Treatment Overview

Obesity management is multimodal which combines lifestyle, pharmacological, and surgical strategies. Lifestyle interventions include diet modification, increased physical activity, and behavioral therapy. Pharmacotherapy, such as GLP-1 receptor agonists, orlistat, and other approved medications, may be indicated for patients with BMI ≥30 or ≥27 with comorbidities. Bariatric surgery is considered for severe obesity, offering significant weight reduction and improvement in metabolic complications. Long-term success relies on continuous follow-up, adherence to lifestyle changes, and management of comorbid conditions. Personalized plans are essential to optimize safety and efficacy.

Key Questions Answered

• What are the key findings of obesity epidemiology in the 8 major markets?
• What will be the total number of patients with Obesity across the 8 major markets during the forecast period?
• What was the country-wise Obesity epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cases of Obesity during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of Obesity during the forecast period of 2026-2035?
• What are the currently available treatments for Obesity?
• What are the disease risks, signs, symptoms, and unmet needs of Obesity?

Scope of the Obesity Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Obesity based on several factors.
• Obesity Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The Obesity report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Obesity Market

Weight Loss and Weight Management Diet Market

Obesity Drug Pipeline Analysis